Lilly Diabetes Launches Mobile Application for Those Who Support People with Type 1 Diabetes
... App serves as a teaching tool and can provide guidance for treatment with Lilly Glucagon for Injection (rDNA origin) during severe hypoglycemic events
Submitted by Lilly Diabetes for inclusion in this website
For Release: September 4, 2012
Refer to: Refer to: (317) 627-4056 (office) – Julie Williams, Communications Manager
Refer to: (646) 500-7718 (office) – Linda Ruckel, MSLGROUP
INDIANAPOLIS — September 4, 2012 – Lilly Diabetes today announced the release of a new mobile application designed for caregivers and healthcare providers who support people with type 1 diabetes. The Lilly Glucagon Mobile App is a tool to teach how to use Glucagon for Injection, through simulated practice. Glucagon, 1 mg (1 unit), is indicated to treat severe hypoglycemia (low blood sugar).
Download PDF here: